Back

Sarcomatrix extends accredited investor round to October 31, 2026

Verifying
  • Sarcomatrix extended its accredited investor financing round through October 31, 2026.
  • October 31, 2026, is the new scheduled closing date, subject to earlier full subscription.
  • Sarcomatrix is preparing GLP safety studies before seeking authorization for human testing.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.